potassium iodide has been researched along with Postoperative Complications in 9 studies
Potassium Iodide: An inorganic compound that is used as a source of iodine in thyrotoxic crisis and in the preparation of thyrotoxic patients for thyroidectomy. (From Dorland, 27th ed)
potassium iodide : A metal iodide salt with a K(+) counterion. It is a scavenger of hydroxyl radicals.
Postoperative Complications: Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Potassium iodide (KI) has traditionally been used to reduce gland vascularity and diminish blood loss in patients undergoing thyroidectomy for Graves disease (GD)." | 7.79 | Is potassium iodide solution necessary before total thyroidectomy for Graves disease? ( Baker, A; Broome, JT; Shinall, MC; Solorzano, CC, 2013) |
| "Potassium iodide (KI) treatment affects the vascularity of the thyroid gland and therefore may improve intraoperative visualization of essential structures." | 5.56 | Preoperative Potassium Iodide Treatment in Patients Undergoing Thyroidectomy for Graves' Disease-Perspective of a European High-Volume Center. ( Fendrich, V; Kußmann, J; Lindner, K, 2020) |
| "Potassium iodide (KI) has traditionally been used to reduce gland vascularity and diminish blood loss in patients undergoing thyroidectomy for Graves disease (GD)." | 3.79 | Is potassium iodide solution necessary before total thyroidectomy for Graves disease? ( Baker, A; Broome, JT; Shinall, MC; Solorzano, CC, 2013) |
| "Potassium iodide (KI) treatment affects the vascularity of the thyroid gland and therefore may improve intraoperative visualization of essential structures." | 1.56 | Preoperative Potassium Iodide Treatment in Patients Undergoing Thyroidectomy for Graves' Disease-Perspective of a European High-Volume Center. ( Fendrich, V; Kußmann, J; Lindner, K, 2020) |
| "1." | 1.25 | Thyroid failure after potassium iodide treatment of diffuse toxic goiter. ( Maloof, F; Wood, LC, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (44.44) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Lindner, K | 1 |
| Kußmann, J | 1 |
| Fendrich, V | 1 |
| Randle, RW | 1 |
| Bates, MF | 1 |
| Long, KL | 1 |
| Pitt, SC | 1 |
| Schneider, DF | 1 |
| Sippel, RS | 1 |
| Shreyamsa, M | 1 |
| Mouli, VS | 1 |
| Singh, KR | 1 |
| Ramakant, P | 1 |
| Mishra, A | 1 |
| Shinall, MC | 1 |
| Broome, JT | 1 |
| Baker, A | 1 |
| Solorzano, CC | 1 |
| van de Loo, J | 1 |
| Boudewyns, A | 1 |
| Claes, J | 1 |
| Wood, LC | 1 |
| Maloof, F | 1 |
| Bergmann, F | 1 |
| Clercx, L | 1 |
| Deschreyer, M | 1 |
| Dor, P | 1 |
| Gevens, J | 1 |
| Niederkorn, A | 1 |
| Rocmans, P | 1 |
| Van Geertruyden, J | 1 |
| Wilputte, F | 1 |
| Altman, RP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Preoperative Lugol's Solution in Graves' Disease and Toxic Nodular Goiter[NCT04856488] | Phase 3 | 182 participants (Anticipated) | Interventional | 2021-11-18 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
9 other studies available for potassium iodide and Postoperative Complications
| Article | Year |
|---|---|
Preoperative Potassium Iodide Treatment in Patients Undergoing Thyroidectomy for Graves' Disease-Perspective of a European High-Volume Center.
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Child; Female; Graves Disease; Humans; | 2020 |
Impact of potassium iodide on thyroidectomy for Graves' disease: Implications for safety and operative difficulty.
Topics: Adult; Female; Graves Disease; Humans; Male; Middle Aged; Postoperative Complications; Potassium Iod | 2018 |
Impact of potassium iodide on thyroidectomy for Graves' disease: implications for safety and operative difficulty.
Topics: Graves Disease; Humans; Postoperative Complications; Potassium Iodide; Thyroidectomy | 2019 |
Is potassium iodide solution necessary before total thyroidectomy for Graves disease?
Topics: Adult; Combined Modality Therapy; Female; Follow-Up Studies; Goiter, Nodular; Graves Disease; Humans | 2013 |
[The preoperative medical evaluation of the aged woman].
Topics: Aged; Blood Coagulation Disorders; Cardiovascular Diseases; Diabetes Mellitus; Female; Heparin; Huma | 1980 |
Acute cochleovestibular toxicity due to topical application of potassium iodide.
Topics: Administration, Topical; Adult; Audiometry, Pure-Tone; Hearing Loss, Sudden; Humans; Male; Medicatio | 2001 |
Thyroid failure after potassium iodide treatment of diffuse toxic goiter.
Topics: Adult; Aged; Female; Follow-Up Studies; Graves Disease; Humans; Hypothyroidism; Middle Aged; Postope | 1975 |
[Non-neoplastic diseases of the thyroid. Analysis of the immediate and long-term results of 938 thyroidectomies].
Topics: Adolescent; Female; Goiter; Hemorrhage; Humans; Hyperthyroidism; Hypoparathyroidism; Hypothyroidism; | 1973 |
Total thyroidectomy for the treatment of Graves' disease in children.
Topics: Adolescent; Child; Female; Graves Disease; Humans; Hyperthyroidism; Hypocalcemia; Laryngeal Edema; M | 1973 |